NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 1 filers reported holding NABRIVA THERAPEUTICS AG in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $710,000 | -61.7% | 86,710 | -50.9% | 0.16% | -63.2% |
| Q2 2017 | $1,852,000 | -12.7% | 176,710 | 0.0% | 0.44% | -5.0% |
| Q1 2017 | $2,121,000 | +101.4% | 176,710 | 0.0% | 0.46% | +13.8% |
| Q4 2016 | $1,053,000 | -15.5% | 176,710 | 0.0% | 0.41% | -27.1% |
| Q3 2016 | $1,246,000 | -6.0% | 176,710 | 0.0% | 0.56% | -52.5% |
| Q2 2016 | $1,325,000 | -16.3% | 176,710 | 0.0% | 1.18% | -24.1% |
| Q1 2016 | $1,583,000 | -6.2% | 176,710 | 0.0% | 1.55% | +6.3% |
| Q4 2015 | $1,688,000 | – | 176,710 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,021,559 | $23,968,000 | 7.90% |
| Omega Fund Management, LLC | 1,145,890 | $6,830,000 | 5.54% |
| ACUTA CAPITAL PARTNERS, LLC | 706,383 | $4,210,000 | 1.57% |
| Novo Holdings A/S | 2,326,544 | $13,866,000 | 1.32% |
| FT Options LLC | 83,055 | $494,000 | 0.57% |
| EcoR1 Capital, LLC | 264,773 | $1,578,000 | 0.50% |
| Boxer Capital, LLC | 176,710 | $1,053,000 | 0.41% |
| Rock Springs Capital Management LP | 525,000 | $3,124,000 | 0.21% |
| Orbimed Advisors | 1,677,940 | $10,001,000 | 0.13% |
| Hillhouse Capital Management | 700,000 | $4,165,000 | 0.09% |